Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.35 |
| ▸ | MGLL | Q99685 | 5/20 | 0.34 |
| ▸ | FAAH | O00519 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | XBP1 | P17861 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16484921 | 1.00 | CYP1B1 (0.35) | CYP1B1MGLLFAAHALDH1A1LMNA | |
| SCHEMBL485615 | 0.86 | MGLL (0.44) | CYP1B1MGLLFAAHALDH1A1LMNA | |
| SCHEMBL1920814 | 0.79 | HTR1A (0.37) | POLB | |
| SCHEMBL4400934 | 0.78 | CYP1B1 (0.34) | CYP1B1ALDH1A1LMNAHPGDCYP3A4 | |
| SCHEMBL20365061 | 0.78 | CYP1B1 (0.44) | CYP1B1MGLLFAAHALDH1A1LMNA | |
| SCHEMBL5531964 | 0.77 | HPGD (0.38) | CYP1B1MGLLFAAHALDH1A1LMNA | |
| SCHEMBL1707544 | 0.77 | MGLL (0.41) | CYP1B1MGLLFAAHALDH1A1LMNA | |
| SCHEMBL4761414 | 0.77 | MGLL (0.46) | CYP1B1MGLLFAAHALDH1A1LMNA | |
| SCHEMBL10147918 | 0.76 | MGLL (0.38) | CYP1B1MGLLFAAHALDH1A1LMNA | |
| SCHEMBL1275809 | 0.76 | CYP1B1 (0.45) | CYP1B1MGLLFAAHALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240240025-A1 | Blue-Excitable Water-Solvated Polymeric Dyes | BECTON, DICKINSON AND COMPANY | 2024-07-18 | — | — | US | disclosed |
| CN-117642185-A | Improved CD30 targeting antibody drug conjugates and uses thereof | 路德维希-马克西米利安慕尼黑大学 | 2024-03-01 | — | — | CN | disclosed |
| EP-4328270-A2 | ULTRAVIOLET ABSORBING POLYMERIC DYES AND METHODS FOR USING THE SAME | Becton, Dickinson and Company (US) | 2024-02-28 | — | — | EP | disclosed |
| US-11912876-B2 | Blue-excitable water-solvated polymeric dyes | BECTON, DICKINSON AND COMPANY (US) | 2024-02-27 | — | — | US | disclosed |
| US-11874278-B2 | Reagents for directed biomarker signal amplification | SIRIGEN II LIMITED (GB) | 2024-01-16 | — | — | US | disclosed |
| CN-116917484-A | Ligase fusion proteins and uses thereof | 启德医药科技（苏州）有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-20230288428-A1 | Ultraviolet Absorbing Polymeric Dyes and Methods for Using the Same | BECTON, DICKINSON AND COMPANY | 2023-09-14 | — | — | US | disclosed |
| US-20230273215-A1 | Novel Reagents for Directed Biomarker Signal Amplification | SIRIGEN, INC. | 2023-08-31 | — | — | US | disclosed |
| US-11732138-B2 | Deep ultraviolet-excitable water-solvated polymeric dyes | BECTON, DICKINSON AND COMPANY (US) | 2023-08-22 | — | — | US | disclosed |
| US-20230251264-A1 | Novel Reagents for Directed Biomarker Signal Amplification | SIRIGEN, INC. | 2023-08-10 | — | — | US | disclosed |
| US-9758625-B2 | Polymeric BODIPY dyes and methods for using the same | BECTON, DICKINSON AND COMPANY (US) | 2017-09-12 | — | — | US | disclosed |
| US-9719998-B2 | Ultraviolet absorbing polymeric dyes and methods for using the same | BECTON DICKINSON AND COMPANY (US) | 2017-08-01 | — | — | US | disclosed |
| WO-2017105927-A1 | POLYMERIC DYE RATIOMETRIC SENSOR FOR ANALYTE DETECTION AND METHODS OF USING THE SAME | BECTON, DICKINSON AND COMPANY (US) | 2017-06-22 | — | — | WO | disclosed |
| US-20170174892-A1 | PHOTOSTABLE FLUORESCENT POLYMERIC TANDEM DYES INCLUDING LUMINESCENT METAL COMPLEXES | BECTON, DICKINSON AND COMPANY | 2017-06-22 | — | — | US | disclosed |
| WO-2017105928-A1 | PHOTOSTABLE FLUORESCENT POLYMERIC TANDEM DYES INCLUDING LUMINESCENT METAL COMPLEXES | BECTON, DICKINSON AND COMPANY (US) | 2017-06-22 | — | — | WO | disclosed |
| EP-1572242-B1 | IMMUNOCONJUGATES WITH AN INTRACELLULARLY-CLEAVABLE LINKAGE | IMMUNOMEDICS INC (US) | 2014-04-16 | — | — | EP | disclosed |
| US-7364739-B2 | Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2008-04-29 | — | — | US | disclosed |
| US-20070207952-A1 | Long Acting Biologically Active Conjugates | SEQUOIA PHARMACEUTICALS (US) | 2007-09-06 | — | — | US | disclosed |
| EP-1620120-A2 | LONG ACTING BIOLOGICALLY ACTIVE CONJUGATES | Sequoia Pharmaceuticals (US) | 2006-02-01 | — | — | EP | disclosed |
| WO-2004085505-A2 | LONG ACTING BIOLOGICALLY ACTIVE CONJUGATES | SEQUOIA PHARMACEUTICALS, INC. (US) | 2004-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11874278-B2 | Reagents for directed biomarker signal amplification | RNGTT, CAPG, CA14 | CYP1B1 4874/4885MGLL 4274/4885FAAH 4217/4885 |
| US-20070207952-A1 | Long Acting Biologically Active Conjugates | ALB, ACE, VIP | CYP1B1 4050/4885MGLL 3789/4885FAAH 2574/4885 |
| US-20230251264-A1 | Novel Reagents for Directed Biomarker Signal Amplification | RNGTT, CAPG, CD2BP2 | CYP1B1 4870/4885MGLL 4322/4885FAAH 4147/4885 |
| US-20230273215-A1 | Novel Reagents for Directed Biomarker Signal Amplification | RNGTT, CAPG, CD2BP2 | CYP1B1 4870/4885MGLL 4322/4885FAAH 4147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.